Cozy Relationship Discovered Between Leukemia Cells and Blood Vessels

Researchers from the University of Florida have uncovered an unusually close relationship between leukemia cells and blood vessels wherein the former are able to embed themselves in the latter and effectively hide from the likes of chemotherapy.

A major issue in the treatment of leukemia is finding a way to reach and kill all the leukemia cells in the body, thereby preventing relapse. In the 1970s it was discovered that leukemia cells were hiding in the central nervous system, leading doctors to begin administering intrathecal chemotherapy as a means of reaching and killing those cells. As a consequence, remission and survival rates went up.

Now, UF Health researchers have discovered another method for these cells to hide-- by integrating themselves into the lining of blood vessels. In doing so, their shape alters, giving them the look of endothelial cells (long, thin cells that line blood vessels).

"There's a protective advantage when leukemia cells integrate within blood vessels," said Christopher R. Cogle, MD, one of the study's lead authors and associate professor of medicine. "The blood vessel walls are a shelter for leukemia cells, and we found that leukemia cells can nestle within blood vessel linings and go to sleep."

Cogle and colleagues believe that these cells are likely responsible for many cases of relapse.

"In the race of survival of the fittest," he added, "leukemia cells that hug blood vessels have a greater chance of withstanding chemotherapy and taking over the body."

He also said that those cells have an easy time collecting much-needed nutrients, and that the solution to killing them will likely involve some manner of either preventing their attachment to the vessels or somehow prying them loose.

Source: UF Health

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap